De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Cigna Group Beheer
Beheer criteriumcontroles 3/4
De CEO Cigna Group's is David Cordani, benoemd in Jun2008, heeft een ambtstermijn van 16.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 21.05M, bestaande uit 7.1% salaris en 92.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.22% van de aandelen van het bedrijf, ter waarde $ 211.77M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.1 jaar en 5.8 jaar.
Belangrijke informatie
David Cordani
Algemeen directeur
US$21.0m
Totale compensatie
| Percentage CEO-salaris | 7.1% |
| Dienstverband CEO | 16.3yrs |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | 4.1yrs |
| Gemiddelde ambtstermijn bestuur | 5.8yrs |
Recente managementupdates
Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being
Apr 18
Recent updates
These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well
Oct 14Cigna: This Dividend Grower Could Be Worth Buying Now
Sep 26Returns On Capital Are Showing Encouraging Signs At Cigna Group (NYSE:CI)
Sep 26Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'
Sep 19The Price Is Right For The Cigna Group (NYSE:CI)
Sep 08Cigna Group: Services Focus Leads To Outperformance
Jul 29Cigna: Game Over For PBMs?
Jul 12Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet
Jun 14Cigna: Will Benefit From Lower Medicaid Enrollments
Jun 11The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing
May 27Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now
May 13Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture
May 09Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being
Apr 18Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why
Apr 09Returns Are Gaining Momentum At Cigna Group (NYSE:CI)
Apr 05Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018
Apr 01Cigna: Trimming The Fat And Staying Focused
Mar 05Cigna: Big Buybacks And Total Return Potential
Feb 26Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40
Feb 05Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap
Jan 29We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Jan 25Why Dividend Growth Investors Should Buy Cigna
Jan 18It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)
Jan 09Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital
Dec 25Cigna: Sentiment And Fundamentals On Their Side
Dec 21Cigna's Merger Fumble: A Festive Financial Rebound
Dec 11Humana And Cigna Topple On Rumors Of An Unlikely Union
Nov 30Cigna Delivering Growth At A Great Price
Nov 13Cigna: Too Cheap To Ignore
Oct 24We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt
Oct 06Cigna: Buy Rating Driven By Undervaluation & Revenue Growth
Oct 01Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return
Sep 21Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape
Sep 14Cigna Group: Weaker Than Peers But Still A Buy
Aug 27Cigna: Buy During The Next Correction (Technical Analysis)
Aug 08Cigna Group (NYSE:CI) Has A Pretty Healthy Balance Sheet
Jul 02Cigna: Buy While It's Still Cheap And Not Loved
Jun 29If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity
Jun 18Cigna: Buy This Value Gem Before It Bounces Back
Jun 12Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture
Jun 04Cigna: Many Reasons To Invest
May 29An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued
May 21Is Cigna Group (NYSE:CI) A Risky Investment?
Mar 24Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$4b |
| Mar 31 2024 | n/a | n/a | US$4b |
| Dec 31 2023 | US$21m | US$2m | US$5b |
| Sep 30 2023 | n/a | n/a | US$5b |
| Jun 30 2023 | n/a | n/a | US$7b |
| Mar 31 2023 | n/a | n/a | US$7b |
| Dec 31 2022 | US$21m | US$2m | US$7b |
| Sep 30 2022 | n/a | n/a | US$7b |
| Jun 30 2022 | n/a | n/a | US$5b |
| Mar 31 2022 | n/a | n/a | US$5b |
| Dec 31 2021 | US$20m | US$2m | US$5b |
| Sep 30 2021 | n/a | n/a | US$8b |
| Jun 30 2021 | n/a | n/a | US$8b |
| Mar 31 2021 | n/a | n/a | US$8b |
| Dec 31 2020 | US$20m | US$2m | US$8b |
| Sep 30 2020 | n/a | n/a | US$5b |
| Jun 30 2020 | n/a | n/a | US$5b |
| Mar 31 2020 | n/a | n/a | US$5b |
| Dec 31 2019 | US$19m | US$2m | US$5b |
| Sep 30 2019 | n/a | n/a | US$4b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$3b |
| Dec 31 2018 | US$19m | US$1m | US$3b |
| Sep 30 2018 | n/a | n/a | US$3b |
| Jun 30 2018 | n/a | n/a | US$3b |
| Mar 31 2018 | n/a | n/a | US$3b |
| Dec 31 2017 | US$18m | US$1m | US$2b |
Compensatie versus markt: De totale vergoeding ($USD 21.05M ) David } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 13.04M ).
Compensatie versus inkomsten: De vergoeding van David is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
David Cordani (59 yo)
16.3yrs
Tenure
US$21,047,255
Compensatie
Mr. David Michael Cordani serves as Chair of the Board at The Cigna Group (formerly known as Cigna Corporation) since January 01, 2022. He has been the Chief Executive Officer and President of The Cigna Gr...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 16.3yrs | US$21.05m | 0.22% $ 215.8m | |
| Executive VP | 3.8yrs | US$7.79m | 0.015% $ 14.8m | |
| Executive VP & Global Chief Information Officer | 4.1yrs | US$5.27m | 0.0060% $ 6.0m | |
| Executive VP | 13.3yrs | US$5.21m | 0.010% $ 10.1m | |
| Executive Vice President of Enterprise Strategy | less than a year | US$8.93m | 0.020% $ 19.8m | |
| Chief Accounting Officer | less than a year | geen gegevens | 0.00043% $ 424.5k | |
| Senior VP & Head of Investor Relations | 2.8yrs | geen gegevens | geen gegevens | |
| Executive VP | no data | geen gegevens | geen gegevens | |
| President of International MArkets & President of International Health Cigna Healthcare | 10.3yrs | US$3.53m | 0.015% $ 14.4m | |
| President of U.S. Government - Healthcare's Medicare & Individual & Family Plan (IFP) Businesses | 1.3yrs | geen gegevens | geen gegevens | |
| Head of Strategy & Global Business Development for Cigna International Markets | 4.6yrs | geen gegevens | geen gegevens | |
| President and GM of Florida & Caribbean Markets | 11.1yrs | geen gegevens | geen gegevens |
4.1yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van CI wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 15yrs | US$21.05m | 0.22% $ 215.8m | |
| Independent Director | 19.7yrs | US$337.78k | 0.0053% $ 5.2m | |
| Independent Director | 13.3yrs | US$335.28k | 0.013% $ 12.5m | |
| Lead Independent Director | 17.5yrs | US$360.28k | 0.0015% $ 1.5m | |
| Independent Director | 4.3yrs | US$337.78k | 0.0014% $ 1.4m | |
| Independent Director | 5.8yrs | US$335.28k | 0.0020% $ 1.9m | |
| Independent Director | 5.8yrs | US$310.28k | 0.0063% $ 6.2m | |
| Independent Director | 5.8yrs | US$310.28k | 0.0020% $ 1.9m | |
| Independent Director | 1.3yrs | US$248.50k | 0.00042% $ 414.6k | |
| Independent Director | 5.8yrs | US$335.28k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$310.28k | 0.0011% $ 1.1m | |
| Independent Director | 3.1yrs | US$310.28k | 0.00098% $ 967.4k |
5.8yrs
Gemiddelde duur
62.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CI wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).